Table: Takara Bio - 9-MTH group results
Feb 14 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2023 Dec 31, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 29.73 60.21 45.50
(-50.6 pct) (+31.9 pct) (-41.8 pct)
Operating 336 mln 19.40 3.00
(-98.3 pct) (-2.6 pct) (-85.4 pct)
Recurring 586 mln 19.48 3.20
(-97.0 pct) (-3.3 pct) (-84.5 pct)
Net 154 mln 14.60 2.00
(-98.9 pct) (+1.6 pct) (-87.5 pct)
EPS 1.28 yen 121.21 yen 16.61 yen
Ann Div 42.00 yen 17.00 yen
-Q2 div NIL NIL
-Q4 div 42.00 yen 17.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T